Development of DNA methylation markers for predicting the prognosis of pancreatic cancer.

e16216Background: Pancreatic cancer is an extremely malignant tumor that is associated with low survival rates. Currently, TNM staging, serum CA19–9, CA125 and CEA are used to assess the risk level...